Indication

Disseminated mycobacterium avium complex infection

Disseminated *Mycobacterium avium* complex infection is a severe, multi-organ systemic illness caused by ubiquitous nontuberculous mycobacteria, primarily *Mycobacterium avium* and *Mycobacterium intracellulare*. Read more about Disseminated mycobacterium avium complex infection

23 drugs 22 manufacturers

Advertisement

Drugs that treat it

Common Disseminated mycobacterium avium complex infection therapies.

Showing 1–9 of 23 drugs

CLARITHROMYCIN

MACROLIDE ANTIBIOTICS·DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
SANDOZ

CLARITHROMYCIN

MACROLIDE ANTIBIOTICS·DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
SANDOZ

CLARITHROMYCIN

DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
APOTEX CORP

CLARITHROMYCIN

MACROLIDE ANTIBIOTICS·DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
AUROBINDO PHARM

CLARITHROMYCIN

DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
ROXANE LABS.

CLARITHROMYCIN

DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
CITRON PHARMA L

CLARITHROMYCIN

MACROLIDE ANTIBIOTICS·DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
Lannett Company

CLARITHROMYCIN

DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
ROXANE/WEST-WAR

CLARITHROMYCIN

DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
CADISTA PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Disseminated mycobacterium avium complex infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Disseminated mycobacterium avium complex infection.

Disseminated *Mycobacterium avium* complex infection is a severe, multi-organ systemic illness caused by ubiquitous nontuberculous mycobacteria, primarily *Mycobacterium avium* and *Mycobacterium intracellulare*.

It predominantly develops as an opportunistic infection in severely immunocompromised individuals, most notably those with advanced human immunodeficiency virus infection presenting with CD4 T-lymphocyte counts below 50 cells/µL, as well as transplant recipients or other heavily immunosuppressed patients.

Pathophysiologically, the bacteria translocate across the mucosal barrier of the gastrointestinal or respiratory tract and spread hematogenously to the reticuloendothelial system and other organ tissues, leading to high-grade mycobacteremia.

Clinically, it is characterized by chronic, debilitating constitutional signs, including high fevers, drenching night sweats, involuntary weight loss, fatigue, profound anemia, hepatosplenomegaly, and lymphadenopathy.

Personalize your experience

Follow Disseminated mycobacterium avium complex infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it